跳至主要内容
临床试验/CTRI/2019/08/020754
CTRI/2019/08/020754尚未招募不适用

A prospective,randomized comparative clinical study to compare the safety and efficacy of different Hydrophobic Aspheric Monofocal Intraocular lenses

Biotech healthcare Pvt Ltd1 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2019年8月19日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
168
试验地点
1
主要终点
To compare the visual outcomes, contrast sensitivity and patient satisfaction after IOL implantation

研究概览

简要总结

This is a prospective, randomised, single centre, comparative clinical study to evaluate the safety and efficacy ( visual outcomes, contrast sensitivity and patient satisfaction) of different hydrophobic aspheric monofocal intraocular lenses on patients, 18 years and older, undergoing cataract surgery fulfilling the inclusion criteria and who are willing to participate in the clinical trial. Optiflex genesis, Eyecrylplus ASHFY600 and Tecnis 1 are the three investigational IOLs being used in the study. Sample size of 168 eyes (56 eyes in each arm) considering 20% drop out rate is required to prove the null hypothesis mean change in BCVA for all the three investigational products are same vs the alternative hypothesis of unequal mean change in BCVA.

研究设计

研究类型
Interventional
分配方式
Permuted block randomization, fixed
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • age 18 and older Best corrected visual acuity to be 0.2 logmar or lower cataract calculated IOL power within range of investigational IOL subjects are willing and understand and sign informed consent subjects are willing and able to attend postoperative examinations as per schedule.

排除标准

  • previous intraocular and corneal surgery pregnancy and lactation traumatic cataract concurrent participation in another drug or device study chronic uveitis patients receiving chloroquine treatment corneal dystrophy or endothelial insufficiency microphthalmia active ocular diseases( active diabetic retinopathy, uncontrolled glaucoma).

结局指标

主要结局

To compare the visual outcomes, contrast sensitivity and patient satisfaction after IOL implantation

时间窗: Time-frame: pre-op, 1,7, 30,90,180 and 365 days follow up

Uncorrected visual acuity

时间窗: Time-frame: pre-op, 1,7, 30,90,180 and 365 days follow up

best corrected visual acuity

时间窗: Time-frame: pre-op, 1,7, 30,90,180 and 365 days follow up

contrast sensitivity

时间窗: Time-frame: pre-op, 1,7, 30,90,180 and 365 days follow up

次要结局

  • high order aberrations(manifest refraction)

研究者

发起方
Biotech healthcare Pvt Ltd
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验

A prospective clinical study to compare the safety... | 临床试验